D-Wave, Quantum

D-Wave Quantum Endures 7.8% Selloff Amid Dilution and IPO Pressure, but Backlog and Margin Targets Offer a Counter-Narrative

04.06.2026 - 04:12:30 | boerse-global.de

D-Wave Quantum fell 7.8% after government CHIPS funding dilution and rival Quantinuum's IPO, but investor day unveiled margin targets and a $33.4M bookings quarter, signaling commercial progress.

D-Wave Quantum Endures 7.8% Selloff Amid Dilution and IPO Pressure, but Backlog and Margin Targets Offer a Counter-Narrative - Bild: ĂĽber boerse-global.de
D-Wave Quantum Endures 7.8% Selloff Amid Dilution and IPO Pressure, but Backlog and Margin Targets Offer a Counter-Narrative - Bild: ĂĽber boerse-global.de

The quantum computing specialist D-Wave Quantum found itself on the wrong side of the tape Wednesday, with shares sliding 7.8 per cent to $27.57 as roughly 41.6 million shares changed hands — nearly 28 per cent above the daily average. The selloff, however, tells only part of the story. Beneath the surface, the company used its recent investor day to lay out margin targets, a beefed-up customer roster and a bookings pipeline that analysts say lends increasing credibility to the commercial narrative.

Two distinct forces drove the retreat. First, the US government’s plan to funnel roughly $100 million from the CHIPS programme into D-Wave comes with a catch: the Commerce Department will receive a non-controlling equity stake in return. That dilution — more shares outstanding for the same enterprise value — spooked shareholders into booking profits. Second, rival Quantinuum launched its Nasdaq IPO on June 4, seeking a valuation of up to $14.3 billion, roughly ten times D-Wave’s current market cap. Market participants appear to be rotating capital out of established names like D-Wave and IonQ into the newcomer, which boasts Fortune-500 backing and a broader product suite.

Yet the fundamentals the company presented at its investor day paint a more nuanced picture. D-Wave, long known for its annealing systems, now positions itself as a dual-platform provider of both annealing and gate-model quantum computing. Management for the first time provided clear margin corridors: Quantum Computing-as-a-Service is expected to deliver 65–75 per cent gross margins, Professional Services 40–50 per cent, and Quantum Computing Systems 75–90 per cent. These targets give investors a framework to judge future quarters.

Capacity data also came into focus. Four annealing systems currently power the cloud service Leap, representing an annual revenue capacity of $100 million to $120 million. Each additional production system costs around $2 million and can be built and calibrated in less than four months, underscoring how quickly D-Wave could scale.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Bookings, the more forward-looking metric, surged to $33.4 million in the first quarter, dwarfing the year-ago figure. Two deals stand out: a $20 million system sale to Florida Atlantic University and a two-year, $10 million cloud contract with a Fortune-100 company. Total remaining performance obligations amounted to $42.4 million at the end of March, with roughly 54 per cent expected to convert into revenue within the next twelve months. That conversion will be the next critical test.

The revenue line itself remains the weak spot. First-quarter revenue collapsed 81 per cent year over year to $2.9 million, missing the $4.19 million consensus estimate. The prior-year period had been buoyed by a large system sale. D-Wave posted an operating loss of $18.4 million. Investors are clearly impatient for the backlog to start showing up on the profit-and-loss statement.

On the balance sheet, D-Wave has firepower. Cash and equivalents stood at $588.4 million at quarter-end, even after the $250 million acquisition of Quantum Circuits. That war chest gives the company breathing room to invest in sales and technology.

Analysts remain broadly bullish despite the stock’s stumble. B. Riley Securities lifted its price target from $36 to $40 on Wednesday, reiterating a Buy, citing “promising commercial insights” from the investor day. Stifel held its target at $35 and kept a Buy rating, noting that the presentation supports the long-term story but does not yet justify higher near-term estimates. The Wall Street average stands at $37.50, implying roughly 25 per cent upside from current levels. Eleven of twelve analysts rate the shares Buy; one says Hold.

Bolstering the bull case is the visible sales engine. D-Wave more than doubled its quota-carrying sales headcount over the past 18 months, up 220 per cent, while the technical solutions team grew 129 per cent. The company has publicly named 26 customers signed in the last 18 months, including Anduril Industries, AT&T, BASF, Boeing, Pfizer, NTT Docomo and the U.S. Army Engineer Research and Development Center. Such blue-chip references help ground the quantum thesis in commercial reality.

D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.

Technically, the stock still trades 34.7 per cent above its 50-day moving average and 14.9 per cent above the 200-day line, though it sits 38.5 per cent below its 52-week high. The decline Wednesday, while sharp, does not erase the recent rally: on a monthly basis, D-Wave remains 32 per cent higher in Frankfurt trading.

The central tension for D-Wave is now clear. The company has demonstrated capacity, customer traction and a growing order book. But the market is waiting for that commercial momentum to translate into consistent, recurring revenue. Until the backlog becomes cash flow, volatility will likely remain the norm for this quantum pioneer.

Ad

D-Wave Quantum Stock: New Analysis - 4 June

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

en | US26740W1099 | D-WAVE | boerse | 69480176 |